Novo Nordisk A/S (NVO)
Novo Nordisk A/S Max Pain By Strike
NVO trades at $54.91, pinned near the near-term max pain of $54 expiring Sep 12, 2025 (-1 days). Price stability likely with balanced options positioning at this level. Max pain is stable across expirations ($45-$62.5), indicating stable market expectations. Key magnetic zone at 55 where 10 expirations converge.
Novo Nordisk A/S Max Pain By Expiry
Max pain for NVO shows stable levels around 55.03, reflecting balanced market expectations. The 32% spread signals divergent expectations across timeframes. Most levels above 54.91 could support dips. Strong magnetic level at 55 (10 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 12, 2025 | 54 | -0.91 (-1.67%) |
| Sep 19, 2025 | 55 | 0.09 (0.15%) |
| Sep 26, 2025 | 55 | 0.09 (0.15%) |
| Oct 3, 2025 | 55 | 0.09 (0.15%) |
| Oct 10, 2025 | 55 | 0.09 (0.15%) |
| Oct 17, 2025 | 55 | 0.09 (0.15%) |
| Oct 24, 2025 | 54 | -0.91 (-1.67%) |
| Nov 21, 2025 | 55 | 0.09 (0.15%) |
| Dec 19, 2025 | 55 | 0.09 (0.15%) |
| Jan 16, 2026 | 62.5 | 7.59 (13.81%) |
| Mar 20, 2026 | 55 | 0.09 (0.15%) |
| Jun 18, 2026 | 55 | 0.09 (0.15%) |
| Sep 18, 2026 | 55 | 0.09 (0.15%) |
| Jan 15, 2027 | 60 | 5.09 (9.26%) |
| Dec 17, 2027 | 45 | -9.91 (-18.06%) |